by McKesson Ventures | Aug 6, 2020 | Press Releases
Cancer detection company GRAIL has announced that Cleveland Clinic has joined GRAIL’s PATHFINDER Study, a prospective, multi-cancer clinical study that is evaluating the implementation of Galleri™, an investigational multi-cancer early detection blood test, into...
by McKesson Ventures | Jul 7, 2020 | Portfolio News
While COVID-19 has justifiably been at the top of healthcare news, a major medical breakthrough has been quietly happening in the San Francisco Bay area—one that could detect another potentially fatal disease before it’s too late: Cancer. And the company responsible...
by McKesson Ventures | Jun 2, 2020 | Portfolio News
GRAIL will bring 398 jobs to Durham, N.C., over the next five years, effectively doubling its workforce. The company landed an incentive package from the state of North Carolina valued at $5.7 million, and Durham County also pledged $678,000 in incentives. In return,...
by McKesson Ventures | May 12, 2020 | Portfolio News
GRAIL has announced that two of its executives will be speaking at the BofA Securities 2020 Health Care Conference. Hans Bishop, Chief Executive Officer; and Joshua Ofman, MD, MSHS, Chief Medical Officer and External Affairs, will provide an overview of the company at...
by McKesson Ventures | May 6, 2020 | Portfolio News
GRAIL announced that it has completed a $390 million Series D financing round. New investors including Public Sector Pension Investment Board (PSP Investments), Canada Pension Plan Investment Board (CPP Investments), and two undisclosed investors joined existing...
